Sabra Health (Germany) Analysis

Sabra Stock Analysis Notes

About 90.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.9. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sabra Health Care recorded a loss per share of 0.33. The entity last dividend was issued on the 10th of February 2023. As of March 31, 2019, Sabras investment portfolio included 437 real estate properties held for investment 304 Skilled NursingTransitional Care facilities, 88 Senior Housing communities , 23 Senior Housing communities operated by third-party property managers pursuant to property management agreements and 22 Specialty Hospitals and Other facilities, 30 assets held for sale, one investment in a direct financing lease, 20 investments in loans receivable one mortgage loan, two construction loans and 17 other loans, nine preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing Managed communities. As of March 31, 2019, Sabras real estate properties held for investment included 43,884 bedsunits and its unconsolidated joint venture included 7,652 bedsunits, spread across the United States and Canada To find out more about Sabra Health Care contact the company at 772 287 4000 or learn more at https://www.seacoastbanking.com.

Sabra Health Care Investment Alerts

Sabra Health Thematic Classifications

Sabra Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.59 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sabra Health's market, we take the total number of its shares issued and multiply it by Sabra Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Sabra Profitablity

The company has Profit Margin (PM) of (0.15) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.27 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.27.

Technical Drivers

As of the 20th of July, Sabra Health has the Coefficient Of Variation of 9735.28, risk adjusted performance of 0.0143, and Semi Deviation of 1.61. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sabra Health Care, as well as the relationship between them. Please validate Sabra Health Care coefficient of variation, variance, and the relationship between the downside deviation and standard deviation to decide if Sabra Health is priced more or less accurately, providing market reflects its prevalent price of 15.62 per share.

Sabra Health Care Price Movement Analysis

Sabra Health Outstanding Bonds

Sabra Health Predictive Daily Indicators

Sabra Health Forecast Models

Sabra Health's time-series forecasting models are one of many Sabra Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sabra Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Sabra Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sabra shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Sabra Health. By using and applying Sabra Stock analysis, traders can create a robust methodology for identifying Sabra entry and exit points for their positions.

When running Sabra Health's price analysis, check to measure Sabra Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sabra Health is operating at the current time. Most of Sabra Health's value examination focuses on studying past and present price action to predict the probability of Sabra Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sabra Health's price. Additionally, you may evaluate how the addition of Sabra Health to your portfolios can decrease your overall portfolio volatility.